Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design

NCT05642676 | Withdrawn

• 1 other identifier: MED-2023-32453'
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to test the feasibility and acceptability of implementing clinic system changes and physical structures in Uganda to improve aesthetics, welcome, and privacy to reduce HIV stigma, improve retention-in-care, and improve the patient experience. To evaluate pilot/implementation outcomes, the outcomes of fidelity, feasibility, and acceptability will be assessed prior to intervention. After the changes are done to two HIV interventions clinics, the outcome surveys will assess if the changes were disruptive or impeded the workings of the clinics.

Conditions

Hiv

Outcome Measures

Primary Outcomes (4)

• Acceptability survey

  How well an intervention will be received by the target population and the extent to which the intervention meets the needs of the target population and organizational setting. This will be assessed through qualitative evaluation and a quantitative survey from patients and staff.

  Baseline

• Feasibility

  An assessment of the practicality of a proposed idea or project, by assessing recruitment capacity, and ability to complete proposed modifications in clinics. The intervention will be judged feasible if enrollment and metrics can be completed.

  baseline

• Fidelity to the Intervention

  Assesses whether the intervention was delivered as intended, using the intervention plan/checklist

  6-months post intervention

• Outcomes survey

  assesses if the changes were disruptive or impeded the workings of the clinics.

  6-months post intervention

Study Arms (1)

Interventions clinics to be remodeled

EXPERIMENTAL

Other: Clinics remodeling

Interventions

Clinics remodeling OTHER

changes to the clinics will be planned based on baseline surveys

Interventions clinics to be remodeled

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults 18 and older
• Enrolled in the HIV clinics where we are working
• Able to independently consent for interview, survey, or focus group.

You may not qualify if:

• Unable to provide consent
• Does not speak English or Luganda (local language around Kampala and Entebbe)

Sponsors & Collaborators

• University of Minnesota: lead

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55414, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 8, 2022
• First Posted: December 8, 2022
• Study Start: July 30, 2024
• Primary Completion (Estimated): July 30, 2027
• Study Completion (Estimated): July 30, 2027
• Last Updated: September 11, 2025

Record last verified: 2025-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)